Providence Vna Home Health Location: 611 North Perry, Building Ii, 2nd Floor, Spokane, Washington 99202 Ratings: Phone: (509) 534-4300 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Assured Home Health Location: 111 West North River Drive Suite 204, Spokane, Washington 99201 Ratings: Phone: (509) 747-2462 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Gentiva Health Services Location: 8502 North Nevada Street Suite 2, Spokane, Washington 99208 Ratings: Phone: (509) 464-4970 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Assured Home Health Location: 111 W North River Dr Suite 205, Spokane, Washington 99201 Ratings: Phone: (509) 326-2300 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Intrepid Usa Healthcare Services Location: 9715 North Nevada Street, Spokane, Washington 99218 Ratings: Phone: (509) 466-0954 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Waterford On South Hill Home Health Location: 2929 S Waterford Dr, Spokane, Washington 99203 Ratings: Phone: (509) 321-8149 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
Sunshine Home Health Care Location: 10410 E 9th Ave, Spokane, Washington 99206 Ratings: Phone: (509) 321-9050 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.
Obesity is a known risk factor for developing type 2 diabetes. But it hasn't been clear whether the "dose" of obesity—how much excess weight a person has, and for how long—affects the risk of diabetes.
Pharma Major Lupin Limited announced today that its Canadian subsidiary, Lupin Pharma Canada Limited (collectively Lupin) has launched its first Brand product Zaxine under a strategic licensing agreement with the North Carolina based GI specialty company Salix Pharmaceuticals Inc.
Penny by penny, students at Oak Point Intermediate School in Eden Prairie, MN, raised an incredible $42,474.24 through Pennies for Patients, making them the top fundraiser nationwide in The Leukemia & Lymphoma Society's School & Youth Programs.
The WHO is expected to hold a meeting in February to discuss controversy over recent research on the H5N1 bird flu virus, after the U.S. National Scientific Advisory Board for Biosecurity (NSABB) in December advised the journals Science and Nature to withhold publishing two teams' research on the virus for fear the information could "fall into the wrong hands," a commentary in the Economist's "Babbage" blog states.
› Verified 5 days ago